Shopping Cart 0
Cart Subtotal
AED 0

Marinomed Biotech AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Marinomed Biotech AG (Marinomed) formerly Marinomed Biotechnologie GmbH, is a biopharmaceutical company which discovers and develops medicines for the treatment of anti-viral and immunological diseases. Its proprietary anti-viral technology platform MAVIREX, developed Carragelose, an active anti-viral compound that targets different respiratory virus strains based on polymers derived from red seaweed. Marinomed's MAM-06.301 is an anti-allergy compound, which provides an alternative for corticosteroids and anti-histamines. Its OTC products find application in the treatment of asthma, influenza, allergy, allergic rhinitis and chronic obstructive pulmonary disease, among others. It works in partnership with other academic and commercial organizations for the development and commercialization of its products for respiratory and ocular disorders.The company is a spin-off from University of Veterinary Medicine, Vienna. Marinomed is headquartered in Vienna, Austria.

Marinomed Biotech AG-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Marinomed Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Marinomed Biotech AG, Medical Devices Deals, 2012 to YTD 2018 9

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deal Details 11

Licensing Agreements 11

Marinomed Biotech Enters Into Licensing Agreement With International Pharma Company 11

Debt Offering 12

Marinomed Biotech Raises USD8 Million in Private Placement of 4% Bond Due 2021 12

Asset Transactions 13

NicOx Acquires Carragelose from Marinomed Biotech for USD6.9 Million 13

Acquisition 14

aws Mittelstandsfonds Acquires Stake in Marinomed Biotech 14

Marinomed Biotech AG-Key Competitors 15

Marinomed Biotech AG-Key Employees 16

Marinomed Biotech AG-Locations And Subsidiaries 17

Head Office 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Marinomed Biotech AG, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Key Facts 2

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Marinomed Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Marinomed Biotech AG, Deals By Therapy Area, 2012 to YTD 2018 8

Marinomed Biotech AG, Medical Devices Deals, 2012 to YTD 2018 9

Marinomed Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Marinomed Biotech Enters Into Licensing Agreement With International Pharma Company 11

Marinomed Biotech Raises USD8 Million in Private Placement of 4% Bond Due 2021 12

NicOx Acquires Carragelose from Marinomed Biotech for USD6.9 Million 13

aws Mittelstandsfonds Acquires Stake in Marinomed Biotech 14

Marinomed Biotech AG, Key Competitors 15

Marinomed Biotech AG, Key Employees 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Marinomed Biotech AG, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.